Search results
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
FOX 23 News Albany· 4 hours agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
BioPharma Dive via Yahoo Finance· 20 hours agoAstellas Pharma is betting again on cell therapy, announcing Wednesday a deal with Poseida...
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 14 hours agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
Astellas hitches a ride in Poseida's convertible for $50M cell therapy collaboration
FierceBiotech· 12 hours agoThe companies have signed an agreement, via Astellas’ subsidiary Xyphos Biosciences, to develop two ...
OBiO Technology will showcase at American Society of Gene & Cell Therapy
WTNH-TV New Haven· 4 days agoOBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and...
Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
Digital Journal· 13 hours agoFollowing the announcement, the Company will host a live webcast...
Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema
Digital Journal· 2 days agoEmmecell Logo EO2002 is a first-in-class, non-surgical cell therapy with the ability to modify disease via Emmecell's exclusive Magnetic Cell Delivery ( ...
Ozzy Osbourne Opens Up About Receiving Stem Cell Therapy For Parkinson's Disease | iHeart
iHeartRadio· 22 hours agoOzzy Osbourne has been plagued with a number of health problems in the last several years, including...
Bristol Myers Squibb enlists Cellares amid industry manufacturing “land grab”
BioPharma-Reporter· 3 days agoCellares has received a vote of confidence in its integrated and automated cell therapy factories as...
UMSOM Preclinical Study Finds Novel Stem Cell Therapy Boosts Neural Repair After Cardiac Arrest
Newswise· 1 day agoAbout 70 percent of the nearly 7 million people who suffer from cardiac arrest each year experience a long-term brain injury that leads to permanent disability. The potential of stem